NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/08/2025
Back to search
Official data from USPTO
OTREXUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
07/08/2025
Trademark type
Combined
Nice classes
5
Filing date
10/14/2024
Registration date
07/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/08/2025
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2016-08-00
First use in commerce
2016-08-00
Drawing code
3
Owner type
16
Owner location
LAKE FOREST, IL
Examiner
SHINER, MARK W
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists consists of the word "OTREXUP" in Chino Medium font and in the color orange with the letter "O" capitalized. There is a sweeping element in the form of three wave like symbols, the first of which is just above the letter "U" and entirely in the color blue; the second and third wave like symbols begin to the right of the letter "P". The middle wave like symbol is in the color orange except for the top third which is in the color blue and arches over the letter "P". The final wave like symbol is entirely in the color orange and follows the curve of the middle symbol but does not stretch over any of the letters.
Holders and representatives
Holders
Otter Pharmaceuticals, LLC
Representatives
Tim Burgdorf
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-arthritic compositions and preparations; anti-inflammatories; chemical preparations for pharmaceutical or medical purposesfor treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the treatment and prevention of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseasesrheumatoid arthritisjuvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for auto immune diseases and inflammatory diseases; pharmaceutical preparations for auto immune diseases and inflammatory diseasesarthritisjuvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of joint disease; preparation for the relief of pain
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/20/2025
PUBO
PUBLISHED FOR OPPOSITION
05/20/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/14/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2025
DOCK
ASSIGNED TO EXAMINER
04/17/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2025
NWAP
NEW APPLICATION ENTERED
10/14/2024
Continuous trademark protection
Get notified about every new filing that threatens OTREXUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.